In the News October 28, 2020

The Pink Sheet | COVID-19 Vaccines: FDA’s Broad Authority to Craft Narrow EUAs May Push Agency Out of Its Comfort Zone

Cathy Burgess is quoted on the potential impact of the U.S. Food and Drug Administration’s plan to tailor an emergency use authorization to a COVID-19 vaccine.
Media Contact
Alex Wolfe
Communications Director

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.